Quarterly report pursuant to Section 13 or 15(d)

Segments - Operations and Assets Information (Details)

v3.19.1
Segments - Operations and Assets Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Segment Reporting Information [Line Items]      
Total revenues $ 222,451 $ 254,914  
Operating loss (75,318) (42,611)  
Depreciation and amortization 23,816 24,757  
Net income (loss) from investment in investees (1,854) (2,456)  
Assets 2,575,301   $ 2,451,072
Goodwill 698,522   700,193
United States      
Segment Reporting Information [Line Items]      
Total revenues 184,894 215,311  
Ireland      
Segment Reporting Information [Line Items]      
Total revenues 20,534 17,282  
Chile      
Segment Reporting Information [Line Items]      
Total revenues 7,865 11,733  
Spain      
Segment Reporting Information [Line Items]      
Total revenues 4,418 5,532  
Israel      
Segment Reporting Information [Line Items]      
Total revenues 3,116 3,614  
Mexico      
Segment Reporting Information [Line Items]      
Total revenues 1,531 1,420  
Other      
Segment Reporting Information [Line Items]      
Total revenues 93 22  
Corporate      
Segment Reporting Information [Line Items]      
Operating loss (12,272) (11,645)  
Depreciation and amortization 19 30  
Net income (loss) from investment in investees 0 0  
Assets 178,706   52,413
Goodwill 0   0
Pharmaceutical | Operating Segments      
Segment Reporting Information [Line Items]      
Operating loss (29,477) (22,948)  
Depreciation and amortization 7,526 6,740  
Net income (loss) from investment in investees (1,854) (2,172)  
Assets 1,230,811   1,236,499
Goodwill 245,735   247,407
Diagnostics | Operating Segments      
Segment Reporting Information [Line Items]      
Operating loss (33,569) (8,018)  
Depreciation and amortization 16,271 17,987  
Net income (loss) from investment in investees 0 (284)  
Assets 1,165,784   1,162,160
Goodwill 452,787   $ 452,786
Services      
Segment Reporting Information [Line Items]      
Total revenues 178,891 211,315  
Services | Corporate      
Segment Reporting Information [Line Items]      
Total revenues 0 0  
Services | Pharmaceutical | Operating Segments      
Segment Reporting Information [Line Items]      
Total revenues 0 0  
Services | Diagnostics | Operating Segments      
Segment Reporting Information [Line Items]      
Total revenues 178,891 211,315  
Products      
Segment Reporting Information [Line Items]      
Total revenues 25,301 27,851  
Products | Pharmaceutical | Operating Segments      
Segment Reporting Information [Line Items]      
Total revenues 25,301 27,851  
Transfer of intellectual property and other      
Segment Reporting Information [Line Items]      
Total revenues 18,259 15,748  
Transfer of intellectual property and other | Corporate      
Segment Reporting Information [Line Items]      
Total revenues 0 0  
Transfer of intellectual property and other | Pharmaceutical | Operating Segments      
Segment Reporting Information [Line Items]      
Total revenues 18,259 15,748  
Transfer of intellectual property and other | Diagnostics | Operating Segments      
Segment Reporting Information [Line Items]      
Total revenues $ 0 $ 0